ARAV Market Cap History
Below is a table of the ARAV market cap history going back to 10/16/2018:

Date ARAV Market Cap
10/16/201843.19M
10/31/201865.97M
3/8/201974.99M
4/29/201972.73M
5/2/201968.34M
8/1/201974.48M
12/31/201895.67M
10/29/201974.89M
3/16/202052.56M
5/1/2020178.78M
7/28/2020106.68M
10/30/202074.48M
3/10/2021136.64M
5/3/2021109.48M
7/31/202185.96M
10/25/202175.71M
3/25/202240.08M
5/6/202239.20M
8/8/202230.52M
11/4/2022108.29M

Also see: ARAV Shares Outstanding History
and ARAV YTD Return
ARAV Historical Market Cap:
+25.45% CAGR
ARAV Historical Market Cap: +25.45% CAGR

Mouse over chart for data details
10/16/2018 ...11/4/2022
Aravive is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of diseases, including cancer and fibrosis. Co.'s primary product candidate, batiraxcept, is a decoy protein that targets the GAS6-AXL signaling pathway. By capturing serum GAS6, batiraxcept starves the AXL pathway of its signal, potentially halting the biological programming that promotes disease progression. AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression. We show 20 historical shares outstanding datapoints in our ARAV shares outstanding history coverage, used to compute ARAV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARAV market cap history over the course of time is important for investors interested in comparing ARAV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARAV versus a peer is one thing; comparing ARAV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARAV can fluctuate over the course of history. With this page we aim to empower investors researching ARAV by allowing them to research the ARAV market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ARAV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aravive (ARAV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARAY Market Cap History
ARCT Market Cap History
ARDM Market Cap History
ARDS Market Cap History
ARDX Market Cap History
ARMO Market Cap History
ARNA Market Cap History
ARPO Market Cap History
ARQL Market Cap History
ARQT Market Cap History
More Healthcare companies »

 

ARAV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.